MedTrace Logo

Effectiveness of TNI vs. BiPAP in Chronic Global Insufficiency in COPD Patients

NCT02007772 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 105

Last updated 2018-11-15

No results posted yet for this study

Summary

The purpose of this trial ist to investigate the difference of the efficacy of two systems for breath support in patients with COPD.

Conditions

  • COPD Chronic Obstructive Pulmonary Disease

Interventions

DEVICE

nHF

nasal high-flow is used over a period of 6 weeks (outpatient)

DEVICE

BiPAP

BiPAP is used over a period of 6 weeks (outpatient)

Sponsors & Collaborators

  • TNI Medical AG

    collaborator INDUSTRY

  • University of Leipzig

    lead OTHER

Principal Investigators

  • Jens Braeunlich, Dr. · Medical Faculty University Leipzig

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2017-07-31
Completion
2017-07-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02007772 on ClinicalTrials.gov